About this trial
This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.
Eligibility criteria
Qualifiers
Adults ≥ 18 years old
Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days
English speaking
Access to a smartphone (Android or iOS)
Disqualifiers
Prisoners
Patients undergoing cancer surveillance
Trial design
Treatments tested in this trial
- Electronic Health Record Review
- Smartphone Application-based Intervention
- Survey Administration